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ABSTRACT
Background: Neurological  disorder  among  male  premutation  carriers  of  Fragile  X 
Syndrome  (FXS)  frequently  occurs.  In  other  hand,  lacking  of  information  results 
misdiagnosis of this disorder. Therefore this study is addressed to provide the data about 
neurological involvement of late-adult premutation carriers of FXS.
Objectives: This research is to know neurological involvement of late-adult premutation 
carriers of FXS.
Subjects and Methods: This was a descriptive study following cytogenetic, Polymerase 
Chain Reaction (PCR), and neurological examinations on premutation carriers of FXS. 
Cytogenetic and PCR results were secondary data from Central for biomedical research 
(CEBIOR) laboratory of Faculty of Medicine Diponegoro University during September 
2009 – March 2010. Simple neurological examination techniques were done to observe 
neurological involment among male premutation carriers.
Results: There  were  four  males  carrying  premutation  allele  over  the  age  of  50. 
Cytogenetic analysis revealed two subjects expressed fragile site. The other two subjects 
expressed  no  fragile  site.  PCR  analysis  revealed  expanded  allele  from  all  subjects. 
Subject  III.6  showed intention  tremor  and  gait  ataxia,  which  are  two mayor  clinical 
criterions  of  FXTAS. Subject  III.8  showed gait  ataxia  which  is  a  mayor  criterion  of 
FXTAS. Subject  III.9 showed intention  tremor  and gait  ataxia,  which are two mayor 
criterions of FXTAS. And Subject III.10 showed gait ataxia which is a mayor criterion of 
FXTAS.
Conclusion: Some cerebellar manifestations such as intention tremor, limb ataxia, gait 
ataxia, dysdiadochokinesia, and titubation have been identified in premutation carriers of 
FXS. Southern Blot is needed to reveal subjects’s molecular status more accurate. Simple 
techniques to observe mayor and minor clinical criteria in this study had been proved can 
be  used  in  the  future.  Radiological  imaging  is  needed  to  address  major  and  minor 
radiological criteria of FXTAS is still needed as one of an objectives measurement.
 
Keywords : Fragile X-associated Tremor Ataxia Syndrome, intention tremor, gait ataxia, 
cerebellar manifestations
INTRODUCTION
Mental retardation is a common problem in many countries. It is also big problem 
in our country. The effort to diagnose mental retardation precisely is difficult sincemental 
retardation has many variations in clinical and etiological. The genetic causes account for 
25-50% of such cases1. Fragile X syndrome is one of the most prevalent causes of genetic 
mental retardation, with a frequency of 1 in 4,000 males and 1 in 6,000 females2. The 
prevalence of Fragile X Syndrome is 2% in Central Java1. The prevalence of premutation 
carriers alleles of fragile X syndrome in general population is relatively high. In Canadian 
population studies of over 10.000 individuals, the prevalence of premutation alleles of 
Fragile X Syndrome approximately 1 in 259 females and 1 in 813 males3. Prevalence 
estimates for premutationcarriers females were found to be higher in Israel, with 1 in 152 
females. A study of premutation carriers newborn males in Italy is 1 in 250 males3.
The  fragile  X  syndrome  (FXS)  is  aneurodevelopmental  disorder  caused  by 
mutation of the FMR1 geneon the X chromosome. Normally, the FMR1 gene contains 
between 5-50 repeats of the CGG trinucleotide repeats. In fragile X syndrome patients, 
the FMR1 allele has over >200 up to 1,000 repeats. This expansion of the CGG repeats 
results  in  a  methylation  of  FMR1  gene,  results  no  protein  encoded  by  the  FMR1 
gene1,2,3.This methylation of the FMR1 locus in chromosome band Xq27.3 results the 
constriction of the X chromosome in cytogenetic test. Mutation of the FMR1 gene results 
the transcriptional silencing of the fragile X-mental retardation protein, FMRP. In normal 
individuals,  FMRP regulates a population of mRNA2.  FMRP plays  important roles in 
learning and memory,  and also important  in the development  of axons,  synapses  and 
neural  circuits.The  CGGtrinucleotide  repeats  takes  place  as  a  multistep  process  over 
many generations. 
There are four classes of alleles  of CGG trinucleotide repeats according to its 
length. The first class has length between 5-50 CGG repeats called wild type. Second 
class has length between 40-55 CGG trinucleotide  repeats  called protomutation (gray 
zone).  Third  class  has  length  between  50-200  CGG  trinucleotide  repeats  called 
premutation. The fourth class has length between >200 up to 1,000 CGG trinucleotide 
repeats called full mutation2. 
Fragile X syndrome is a neurodevelopmental disorder that is not known to have any 
neurological  problem in late  adult.  Lack of  information  about  it  make  clinician  does 
notrealize that neurological condition such as intention tremor, gait ataxia, parkinsonism, 
and dementia  have  been identified  among  older  males  (45.5%) and females  (15.5%) 
ofpremutation  carriers  of  fragile  X syndrome and it  is  not  a  part  of  aging disorder6. 
Recently, it is thought that this tremor/ataxia syndrome associated with fragile X. This 
clinical features has different mechanism with fragile X syndrome even involving the 
same gene (FMR1). 
The clinical  features of FXTAS are quite  different from FXS. FXTAS involves 
males over 50 years of age. And they have fragile X-affected grandson. Those males do 
not  have  fragile-X  syndrome  such  as  cognitive  decline,  over  60% having  a  college 
education. Actually, there are two form clinical features among premutation carriers of 
Fragile X Syndrome.  The first of these disorders is premature ovarian failure (POF), 
affect  16% to  24% of  female  carriers3,7,8.   The  second  form is  Fragile  X-associated 
Tremor/Ataxia Syndrome (FXTAS). A progressive intention tremor and gait ataxia with 
radiological  abnormality  which  had  been  identified  among  male  carriers,  mostly. 
FXTASare  detected  in  16.5%  of  female  premutation  carriers  and  in  45.5%  of 
malepremutationcarriers older than 50years6,.
Neurological disorder among male premutation carriers of Fragile X Syndrome 
(FXS)  frequently  occurs.  In  other  hand,  lack  of  information  of  this  disorder  results 
misdiagnosis of this disorder. Therefore this study is addressed to provide the data about 
neurological involvement of late-adult premutation carriers of FXS.
The  aim  of  this  research  is  provide  about  neurological  features  among  male 
premutation carriers at Semin, GunungKidul Regency. The advantages of this research 
not only provide data for next research but also provide information for subjects of this 
research and family also. The research about this topic in Indonesia is still insufficient in 
quantity. So that, hopefully this research leads to another new research in other to provide 
more accurate data.
SUBJECT AND METHODS
Subjects
Subjects of this research are all male premutation carriers of Fragile X Syndrome 
over 50 years of ages from a big family who live in Semin, GunungKidul Regency. The 
reachable populations are all male premutation carriers of Fragile X Syndrome over 50 
years  of ages  from a big family who live  in  Semin,  GunungKidul  Regency who are 
examined using cytogenetic test, Polymerase Chain Reaction test, and serial neurological 
examination for tremor and ataxia assessment. This research was using secondary data 
from Central for Biomedical Research (CEBIOR). 
Methods
This  research  was  descriptive-observational  study.  This  research  has  been 
conducted in two places: Central for Biomedical Research (CEBIOR) and research field 
in Semin, GunungKidul Regency. 
Subjects were found using pedigree analysis from affected patients. Then subjects 
were sampled. Heparinized and EDTA periferal blood was drawn for cytogenetic test and 
Polymerase Chain Reaction (PCR) test. Cytogenetic test was done using giemsa staining. 
Meanwhile  DNA  was  extracted  from  leucocytes  of  EDTA  blood  using  salting  out 
method. Then DNA was examined using PCR test. 
After  subjects  molecular  status  was  revealed  by  cytogenetic  and  PCR  test, 
subjects  were  performed  neurological  examination.  These  are  tremor  and  ataxia 
assessment. 
Tremor assessment:
1. Finger to Nose test.  Subjects were asked to abduct their  hand 900 then 
touch plastic marker in front of their nose. Tremor on movement and getting 
worse in the end of movement was assessed as intension tremor (figure 5).
2. Resting tremor test. Subjects were asked to lay their hands on thigh then tremor 
at rest was assessed.
3. Pick  up  coin  test.  Subjects  were  asked  to  pick  up  coin  then  tremor  on  the 
movement was assessed.
4. Pour water test. Subjects were asked to pour water into the glass then tremor on 
the movement and an amount of spilled water was assessed.
Scoring system for tremor assessment using The Fahn TRS (Figure 6). 
Figure 5. Finger to Nose Test. Adopted from Notermans NC et al., 1994
Figure 6. The Fahn TRS. Adopted from Feys PG et al., 2003
Ataxia assessment: 
1. Finger to Nose Test. The same test with tremor test, the difference is ataxia was 
assessed from the distance between the tip of the nose and the final position of 
finger on plastic marker (Figure 5).
2. Upper and lower limb tapping test. On upper limb tapping test, subjects were 
asked to tap the 35 cm-apart-buttons for 15 seconds (Figure 7). On lower limb 
tapping test, subjects were asked to tap the 35 cm-apart-pedals for 15 seconds. 
The result was scored using figure 8. 
Figure 7. Upper limb tapping test. Adopted from Notermans NC et al., 1994
Figure 8. Scoring system of upper and lower tapping test. Adopted from Notermans NC et al., 1994
3. Romberg test. Subjects were asked to stand on heel-to-toe position in opened 
eyes and closed eyes. Then swaying of the body was assessed (Figure 9).
4. Tandem walk test. Subjects were asked to walk on tandem position. Then falling 
to one or both side was assessed (Figure 10).
5. Postural reflex test. Subjects on standing position were pulled then repropulsion 
was assessed. 
Figure 9. Romberg test. Adopted from Lindsay KW et al., 1997
Figure 10. Tandem walk test. Adopted from Linsay KW et al., 1997
RESULTS
Four subjects of this research have range of age from 68 – 74 years old. These 
subjects are found from learning the pedigree construction from the patients of fragile X 
syndrome  from  Semin  Yogyakarta.  One  big  family  with  five  generations  has  been 
identified.  From  physical  and  laboratory  examination  persons  with  pedigree  number 
V:38, V:39, V:40 had been diagnosed as patients with fragile X syndrome. Since fragile 
X syndrome is X-linked disorder, the mother  of persons with pedigree number V:38; 
V:39; V:40, which is IV:35 was suspected as premutation (carrier). Since no selection 
process in maternal meiosis, thus subject IV:35 transmits fullmutation X chromosome to 
her offspring. Person with pedigree number IV:35 is a daughter of subject III:6 (male) so 
that subject III:6 was suspected as premutation too (figure 11). Subject III:6 was 74 years 
old when this research began, so that he was included in this research because he fulfilled 
the inclusion criteria of this research, which is premutation male over 50 years old.  
Figure 11. Pedigree of Subject III.
Another person who was diagnosed as patient with fragile x syndrome is person 
with pedigree number V:53 (female). She is a daughter of person with pedigree number 
IV:43 (female) so that person with pedigree number IV:43 was suspected as premutation 
or fullmutation with a lesser degree of symptoms since fragile X syndrome is X-linked 
disorders with reduce penetrance due to X-inactivation process in females. Person with 
pedigree number IV:43 is a daughter of Subject III:8 (male) thus subject III:8 might be 
premutation  (Figure  12).  In  order  to  confirm  the  assumption,  PCR  test  should  be 
performed.  Subject  III:8  was 72 years  old when this  research  began,  so that  he was 
included in this researchbecause he fulfilled the inclusion criteria of this research, which 
is premutation male over 50 years old.  
Figure 12. Pedigree of Subject III.8
Subject III:6 and Subject III:8 were suspected as premutation, they are sons of 
subject with pedigree number II:2. Subject II:2 has ten children .  So that, Subject II.6 and 
III.8 have eight siblings. Three of them had passed away, no available data about three 
other persons because they refused to be subject in this research. As a result there are four 
available  subjects  fulfilled  inclusion  criteria.  They are subjects  with pedigree  number 
III:6,  III:8,  III:9,  III:10.  All  subjects  are  male  (Figure  in  appendix  IV).  They  was 
performed cytogenetic test, PCR test, and some serial neurological test.
In  order  to  obtain  premutation  involvement  related  to  their  molecular  status, 
cytogenetic test and Polymerase Chain Reaction (PCR) test was performed. Neurological 
examinations using simple techniques to address major clinical criteria of FXTAS which 
are  intention  tremor  and  gait  ataxia  were  performed.  Cytogenetic  analysis  revealed 
subject  III.6  expressed  no fragile  site  when cultured  in  MEM and TC 199 medium. 
Subject III.8 expressed fragile site at  the end of long arm chromosome X when cells 
cultured in medium TC199 and MEM with average frequency 3%. Meanwhile Subject 
III.9 expressed fragile site at the end of long arm chromosome X when cells cultured in 
medium  TC199  and  MEM  with  average  frequency  9%  (figure  13).  Subject  III.10 
expressed no fragile site when cells cultured in MEM and TC 199 medium (table 5).  On 
Polymerase Chain Reaction (PCR) examination, all four subjects showed expanded allele 
(figure 14 and table 5).
Table 5. Cytogenetic and PCR data of four subjects
Figure 13. Positive fragile site in cytogenetic result. There is a constriction or non-staining gap at the 
terminal of X chromosom.
                             GEL 1 GEL 2 GEL 3
Subject Cytogenetic analysis PCR
III.6 M (-) T (-) Expanded allele
III.8 M (+) T (+) 3% Expanded allele
III.9 M (+) T (+) 9% Expanded allele
III.10 M (-) T (-) Expanded allele 
             II.6 II.9   II.11  II.13
Figure 14. PCR results of Subject II.6, II.9, II.11, and II.13.PCR analysis of 4 premutation 
cases is shown in 3 gels i.e. gel 1 from II.6 (∼500bp), gel 2 from II.9 (no product) and II.11 (no product) 
and gel 3 from II.13 (∼500bp)
After  all  subject’s  molecular  status  were  confirmed  by  PCR,  all  subjects 
performed  any  serial  neurologic  examinations  for  tremor  and  ataxia.  These  are 
quantitative tremor results for subject III.6. Subject III.6 performed finger to nose test, by 
abduct his shoulder to 900 and full extension at the elbow then hold the finger on the nose 
for 5 seconds. Then Subject III.6 put down his hands on his thigh in order to observe 
resting tremor. On those tests, subject III.6 showed no resting tremor and no intention 
tremor. On pick up coin test subject III.6 showed slight tremor and occurs in irregular 
interval. On pouring water test subject III.6 spilled small amount of water but less then 
10% total  amount water in glass. The scoring system for quantitative tremor test was 
adopted from specific description in the Fahn TRS (Table 6). This scoring system was 
used for all subjects in this research. 
Table 6. Specific description in the Fahn TRS
General description
0 No tremor
1 Slight, may be intermittent
2 Moderate amplitude, may be intermittent
3 Marked amplitude
4 Severe amplitude
Specific description for pouring-water task
0 Pours normally
1 Pours more carefully than a person without tremor, but no water is 
spilled
2 Spills a small amount of water ( up to 10% of total amount)
3 Spills a considerable amount of water (10%-50%)
4 Unable to pour water without spilling most of it)
These are quantitative ataxia results for subject III.6. Subjects performed tapping 
test by pushed device buttons that placed 35 cm apart for upper limbs then he pushed 
device  pedals  that  placed  35 cm apart.  Tapping  test  can  observe  dysdiadochokinesia 
(difficulty with rapid alternating movement) also. On tapping test subject III.6’s result 
shows less than 50th percentile for upper and lower limb on dominant and non-dominant 
side according to 50th  percentile value of tapping test for ataxia measurement that was 
adopted  from  Notermans  N.C  et  all  (measuring  ataxia:  quantification  based  on  the 
standard neurological examination. Journal of neurology, Neurosurgery, and Psychiatry 
1994; 57:22-26) (Figure 8). Subject III.6 showed no dysdiadochokinesia. Subject III.6 
performed finger to nose test on plastic marker in order to observe limb ataxia. Subject 
III.6 showed no deviation on finger to nose test. Subject III.6 performed Romberg test in 
position heel to toe and tandem walk in order to observe swaying of the body and ability 
to perform tandem walk. Subject III.6 failed on performed Romberg test in position heel 
to  toe,  could  not  walk  in  tandem position.  Subject  III.6  pulled  on  standing position. 
Subject III.6 showed repropulsion on postural reflex test (table 7).
Figure 15. 50th percentile value of tapping test (adopted from Notermans N.C et all 1994)
Table 7. Neurological data of Subject III.6
Pedigree 
number  and 
Age
Quantitative 
Ataxia
Quantitative 
Tremor
Pulling 
test/postural 
reflex:
Dysdiadochokinesia Other  medical 
finding
III.6  
(74 YO)
Upper limb 
tapping test: < 
50th percentile
Resting tremor: 
none
Repropulsion none Hypertension 
(190/130 mmHg)
Lower limb 
tapping test: < 
50th percentile
Finger to nose: 
none
Hearing Impairment
Finger to nose 
(open and closed 
eyes):     0 cm
Pick up coin:   
1 (slight)
Using  cane  since  2 
years ago
Romberg test 
(heel to toe): 
fail
Pouring water: 
2 (Spills < 
10%)
Tandem Walk: 
can not
These are quantitative tremor results for subject III.8. Subject III.8 showed no 
resting tremor and intention tremor on finger to nose test, showed no tremor while subject 
III.8  picked  up the  coin,  and  poured  water  normally  without  spills  water.  These  are 
quantitative ataxia results for subject III.8. On tapping test subject III.8’s result showed 
less than 50th percentile for upper and lower limb on dominant and non-dominant side 
according  to  50th percentile  value  of  tapping  test  for  ataxia  measurement  (the  same 
scoring system to measure other subjects). Subject III.8 showed no dysdiadochokinesia 
on tapping test. Subject III.8 showed no deviation on finger to nose test, tend to fail on 
Romberg  test  with  position  heel  to  toe.  Subject  III.8  could  perform  tandem  walk 
normally. On postural reflex test, subject showed repropulsion but can recover without 
aid (table 8). 
Table 8. Neurological data of Subject III.8
Pedigree 
number  and 
Age
Quantitative 
Ataxia
Quantitative 
Tremor
Pulling 
test/postural 
reflex:
Dysdiadochokinesia Other  medical 
finding
III.8 
(72 YO)
Upper limb 
tapping test: < 
50th percentile
Resting tremor: 
none
Repropulsion but 
recover unaided
None Blood  pressure  : 
120/80 mmHg
Lower limb 
tapping test: < 
50th percentile
Finger to nose: 
none
Hearing Impairment
Finger to nose 
(open and closed 
eyes):     0 cm
Pick up coin: 
0
Romberg test 
(heel to toe): 
tend to fail
Pouring water: 
0
Tandem Walk: 
normal
These are quantitative tremor results for subject III.9. Subject III.9 showed no 
resting tremor and intention tremor on finger to nose test. Subject III.9 showed no tremor 
while subject III.9 picked up the coin, and poured water more carefully than a person 
without tremor, but no water was spilled. These are quantitative ataxia results for subject 
III.9. On tapping test, subject III.9’s result shows less than 50th percentile for upper and 
lower limb on dominant  and non-dominant  side according to 50th percentile  value  of 
tapping test for ataxia measurement (the same scoring system to measure other subjects). 
Subject III.9 showed positive dysdiadochokinesia on tapping test. On finger to nose test, 
subject III.9 showed no deviation.  On Romberg test  with position heel to toe, subject 
III.9, subject tended to fail. Subject III.9 could perform tandem walk step by step but not 
performed it smoothly. On postural reflex, subject III.9 showed normal response (table 
9). 
Table 9. Neurological data of Subject III.9
Pedigree 
number  and 
Age
Quantitative 
Ataxia
Quantitative 
Tremor
Pulling 
test/postural 
reflex:
Dysdiadochokinesia Other  medical 
finding
III.9
(70 YO)
Upper limb 
tapping test: < 
50th percentile
Resting tremor: 
none
Normal Positive Hypertension 
(150/100 mmHg)
Lower limb 
tapping test: < 
50th percentile
Finger to nose: 
none
Hearing Impairment
Finger to nose 
(open and closed 
eyes):     0 cm
Pick up coin: 
0
Romberg test 
(heel to toe): 
tend to fail
Pouring water: 
1 (pours more 
carefully)
Tandem Walk: 
step
These are quantitative tremor results of subject III.10, the fourth subject of this 
research. Subject III.10 showed no resting tremor and intention tremor on finger to nose 
test, showed no tremor while subject picked up coin and poured water normally. Then 
these are quantitative ataxia  results  of subject III.10. On tapping test,  subject III.10’s 
result showed less than 50th percentile for upper and lower limb on dominant and non-
dominant side according to 50th percentile value of tapping test for ataxia measurement 
(the same scoring system to measure other subjects). On finger to nose test, subject III.10 
showed no deviation. On Romberg test with position heel to toe, subject tended to fail. 
Subject could perform tandem walk normally. Subject III.10’s postural reflex was normal 
and did not showed dysdiadochokinesia on tapping test (table 10)
Table 10. Neurological data of Subject III.10
Sampling in order to get data was performed twice to follow up the subjects. Time 
period between first and second observation was one month. Figure below shows number 
of tapping test of subjects on first and second sampling (figure 16). 
Pedigree 
number  and 
Age
Quantitative 
Ataxia
Quantitative 
Tremor
Pulling 
test/postural 
reflex:
Dysdiadochokinesia Other medical finding
III.10
(68 YO)
Upper limb 
tapping test: < 
50th percentile
Resting tremor: 
none
Normal none Hypertension 
(190/130 mmHg)
Lower limb 
tapping test: < 
50th percentile
Finger  to  nose: 
none
Hearing Impairment
Finger to nose 
(open and closed 
eyes):     0 cm
Pick up coin:  0 Using  cane  since  2 
years ago
Romberg test 
(heel to toe):  tend 
to fail
Pouring water: 
0
Tandem Walk: 
normal
Figure 16. Mean of tapping test on first and second sampling.
DISCUSSION
Molecular status of all  subjects has to be done by PCR test  to address 
premutation carrier. Subsequentlyneurological examination was performed to all subjects. 
Subjects were performed some test including tremor and ataxia test. Subjects performed 
Resting tremor test, finger to nose test, pick up coin test, and pour water test. These tests 
were performed to evaluate any resting and intention tremor. Resting tremor is type of 
tremor  when  muscles  are  at  rest.  Tremor  occurs  when  subject  completely  relaxed. 
Meanwhile, Intention tremor is type of on movement tremor that is getting worse in the 
end of movement. Intentional tremor itself is one of clinical manifestations of cerebellar 
disease  meanwhile  resting  tremor  is  one  of  clinical  manifestations  of  parkinsonism 
(figure 17). Therefore resting tremor completely negative in all subject since the basic 
mechanism of FXTAS is cerebellar diseases. Subjects also were performed several kind 
of ataxia tests to test limb ataxia, gait ataxia, titubation and dysdiadochokinesia19,20. 
Figure 17. Resting and intentional tremor. Adopted from Lindsay KW et al., 1997
In order to prove any limb ataxia subjects was performed tapping test for upper 
limb and finger to nose test. To prove any gait ataxia subjects was performed tapping test 
for lower limb, Romberg test, and tandem walk. In cerebellar ataxia, Romberg test will be 
positive in closed eyes and opened eyes (figure 18) To prove any titubationsubjects was 
performed postural reflex or pulling test. Then tapping test also was performed to prove 
any dysdiadochokinesia. Limb ataxia, gait ataxia, titubation and dysdidochokinesia are 
another manifestations of cerebellar disease19. 
Figure 18. The difference between sensory and cerebellar ataxia on Romberg test.Cerebellar 
ataxia shows unsteadiness and clumsiness while opened and closed eyes. Adopted from Lindsay 
KW et al., 1997
Limb ataxia is disorder of smooth and accurate movement of the limb, velocity 
and force of the movement are not checked normally. Gait ataxia is type of gait that is 
wide base (separation of leg), unsteadiness, and irregular steps. Subjects with gait ataxia 
have no ability to perform tandem walk, subjects will fall to one or both side (figure 19). 
Figure 19. The difference between normal gait (left) and gait ataxia (right). Adopted from Lindsay 
KW et al., 1997  
Titubation is clumsiness of the head and trunk. Subjects with this disorder show 
repropulsion on postural reflex test. Dysdiadochokinesia is disorder of ability in perform 
rapid  alternating  movement.  The  normal  rhythm  of  the  movement  interrupted  by 
irregularity of force and speed. Subjects with dysdiadochokinesia show irregular force 
and speed on tapping test20. 
In this  research Subject III.6 showed positive tremor on pick up coin test  and 
pouring water. Subject III.6 also showed positive gait ataxia on Romberg test and tandem 
walk test. Subject III.6 showed positive gait ataxia and intention tremor which are major 
clinical  criterions  of  FXTAS. In order  to  confirm Subject  III.6  as  definite  patient  of 
FXTAS, MRI is needed. Subject III.8 showed no tremor but showed positive gait ataxia 
on tapping test and Romberg test which is major clinical criterion of FXTAS. In order to 
confirm Subject III.8 as patient of FXTAS, other examinations are needed. Examinations 
included MRI, short-term memory, and executive function. Subject III.9 showed tremor 
on pouring water test and showed gait ataxia on tapping test and Romberg test. They are 
two mayor clinical criterions. In order to confirm Subject III.9 as definite, probable or 
possible patient of FXTAS, other examinations are needed. Subject III.10 showed gait 
ataxia  on tapping and Romberg test  which is  mayor  clinical  criterion of FXTAS. To 
confirm  FXTAS  diagnosis  many  test  should  be  perform.  This  research  has  many 
limitations in order to confirm the diagnosis of FXTAS. Many examinations are needed 
to  obtain  other  mayor  and  minor  criterions  such  as  MRI,  Parkinsonism  clinical 
manifestations, short-term memory, and executive functions. 
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